NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Trace Biosciences

Trace Biosciences

Private
Beaverton, OregonHealthcare & Life Scienceshttps://www.trace-bio.com/

Last Round

Grant

Sep 1, 2023

Total Funding Raised

$3.99M

Company Overview

Trace Biosciences is a biotechnology company that develops nerve-targeted fluorescent imaging agents designed to improve surgical safety by enabling real-time visualization of nerves.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Imaging, Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Government Contracts

AI Layer

Application

Keywords

fluorescent imaging agentnerve-targeted imagingintraoperative imagingsurgical visualizationnerve preservationnear-infrared imagingsurgical guidanceimage-guided surgerymolecular imagingsurgical navigationbiotechnologycontrast agentsurgical techmedtechsurgical AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Trace Biosciences Comparables

Compare Trace Biosciences with similar companies based on industry and business-model similarity.

Trace Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Illuminare Biotechnologies
91%
Alume Biosciences
89%
Vergent Bioscience
76%

Trace Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantSep 1, 2023
GrantJul 1, 2023
Pre SeedMay 17, 2023
GrantSep 1, 2022
GrantNov 1, 2021
Accelerator
Apr 1, 2021

Key People

Founding team and executive leadership

Connor Barth

Co-Founder & CEO

Founding Team

Trace Biosciences Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 1, 2021

    Received grant funding from the National Cancer Institute.

Trace Biosciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Trace Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Trace Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersBeaverton, Oregon
Employee Range12
Year Founded2021
Last FundingSep 1, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.